InsiderClue
← All stocks

Climb Bio, Inc.

CLYM Scheduled selling only
CIK 0001768446 #2557 in the set updated 19 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$1.37M
$1.37M on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 1 sales
Net
−$1.37M
$0.00 against sales at will

By person

4 insiders · 1 transaction
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Thomas Stephen Basil
Director
—
$1.37M (1) scheduled
−$1.37M
467,969
0.8148%
$6.40M
−9.5%
RA CAPITAL MANAGEMENT, L.P. entity
Director
—
—
—
3,403,429
5.93%
$46.52M
−85.5%
Brennan Aoife
President and CEO
—
—
—
87,731
0.1527%
$1.20M
+4,910%
Pimblett Emily
SVP, Finance & CAO
—
—
—
18,888
0.0329%
$258.16K
+115.7%

Individual transactions

1
Insider
Date
Role
Action
Shares
Price
Amount
Thomas Stephen Basil
15 Sep 2026
Director
Sold on a plan
100,000
$13.67
$1.37M

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 11 Aug 2021